Hang in there!!, page-155

Strange we don‘t hear about ShORe having completed full enrollment…

ShORe (as well as COAST) is designed to enroll approximately 912-990 treatment naïve patients.

As of December 31, 2023, OPT reported having 198 activated clinical trial sites in ShORe in 22 countries.
As of today, on clinicaltrials.gov (=> click here <=) one can count 191 recruiting trial sites in 21 countries (Kiev in UA understandably not yet recruiting due to the raging war)

And as of April 3, 2024, ShORe stood at 96% enrollment.

Well, this means by April 3, the maximum number of patients still lacking was 44 people (= 990 x (100% - 95,51%)), eventually only 32 people (= 912 x (100% - 96,49%))

And OPT is not able to enroll 32 to 44 people between April 3 and today? With almost 200 trial sites up & running?

That‘s pretty surprising to me. Actually, I would have taken almost any bet on full enrollment in SHORe getting announced by the end of this month. But it seems enrollment in SHORe becomes tougher towards the end. No idea why this is the case…